Header warning

By using the Sites you agree to the terms of this Privacy Policy.

The Privacy Policy explains how Mylan may:

  • collect,
  • use and
  • disclose

information we obtain through the “Sites.” The term “Mylan,” “we” and “us” includes Mylan Inc. and our affiliates and subsidiaries. 

The “Sites” means collectively any website, mobile application or Internet service under the control of Mylan Inc., whether partial or otherwise, in connection with Mylan’s online presence.

Personal Information” means information that alone or when in combination with other information may be used to readily identify, contact or locate you, such as: name, address, email address or phone number. We do not consider Personal Information to include information that has been anonymized so that it does not allow a third party to easily identify a specific individual.

THE SITES COLLECT YOUR INFORMATION

We collect Personal Information when you:
  • use the Sites and
  • communicate with us. 

We also collect information, such as anonymous usage statistics, by using cookies, server logs and other similar technology as you use the Sites.


Using the Sites We collect information you post through the Sites. For example, we collect information when you apply for a job, respond to surveys, post comments or pictures on our social media pages, request information from us or otherwise interact with us online. The Sites will collect the information you provide in such submissions, including any Personal Information.

Customer Relations We may collect Personal Information through your communications with our customer relations team. 

Cookies, Automatic Data Collection and Related Technologies  The Sites collect and store information that is generated automatically as you use it, including your preferences and anonymous usage statistics.

When you visit the Sites, we and our third-party service providers receive and record information on our server logs from your browser, including your IP address, and from cookies and similar technology. Most browsers allow you to block and delete cookies. However, if you do that, the Sites may not work properly.

By using the Sites, you are authorizing us to gather, parse and retain data related to the provision of the Sites.

HOW MYLAN USES YOUR INFORMATION 

We use Personal Information to

  • facilitate and improve our services;
  • communicate with you and
  • respond to your request for information (e.g., to provide refill reminders) unless
    otherwise required by law, regulation or governmental audit.

We may use Personal Information, in aggregate form, for any purpose, including for marketing purposes.


Internal and Service-Related Usage We use information, including Personal Information, for internal and service-related purposes and may provide it to third parties to allow us to facilitate the Sites. We may use and retain any data we collect to provide and improve our services.

Communications We may send email to the email address you provide to us for informational and operational purposes, such as customer service or system maintenance.

Marketing We may use information, including Personal Information, to provide advertising on the Sites and to facilitate transmittal of information about our products or services we think may be useful or relevant to you. We do not rent, sell or share Personal Information about you with other people or nonaffiliated companies for their direct marketing purposes, unless we have your permission. We may allow access to other data collected by the Sites to enable the delivery of online advertising on the Sites, or otherwise facilitate transmittal of information we think may be useful or relevant to you.

Aggregate Data  We may anonymize and aggregate data collected through the Sites and use it for any purpose.

MYLAN MAY DISCLOSE YOUR INFORMATION 

We may share your information:

  • with our third-party service providers;
  • to comply with legal obligations;
  • to protect and defend our rights and property and
  • with your permission.

We do not rent, sell or share Personal Information about you with other people or nonaffiliated companies for their direct marketing purposes, unless we have your permission.


We Use Vendors and Service Providers We may share any information we receive with vendors and service providers retained in connection with the provision of the Sites.

Social Networking and Other Websites The Sites may allow you to share information, including Personal Information, with social networking websites, such as Facebook. We do not share your Personal Information with them unless you direct the Sites to share it. Their use of the information will be governed by their privacy policies, and you may be able to modify your privacy settings on their websites.

As Required By Law and Similar Disclosures We may access, preserve and disclose your Personal Information, other account information and content if we believe doing so is required or appropriate to: comply with law enforcement requests and legal process, such as a court order or subpoena; respond to your requests; or protect your, our or others’ rights, property or safety.

Merger, Sale, or Other Asset Transfers If we are involved in a merger, acquisition, financing due diligence, reorganization, bankruptcy, receivership, sale of Mylan assets or transition of service to another provider, your information may be sold or transferred as part of such a transaction as permitted by law and/or contract. We cannot control how such entities may use or disclose such information.

We may also disclose your Personal Information with your permission.

SECURITY OF YOUR INFORMATION

We take steps to ensure that your information is treated securely and in accordance with this Privacy Policy. Unfortunately, the Internet cannot be guaranteed to be 100% secure, and we cannot ensure or warrant the security of any information you provide to us. We do not accept liability for unintentional disclosure.

By using the Sites or providing Personal Information to us, you agree that we may communicate with you electronically regarding security, privacy and administrative issues relating to your use of the Sites. If we learn of a security system’s breach, we may attempt to notify you electronically by posting a notice on the Sites or sending an email to you. You may have a legal right to receive this notice in writing. To receive free written notice of a security breach (or to withdraw your consent from receiving electronic notice), please notify us at communications@mylan.com.

CHILDREN'S PRIVACY

We do not knowingly collect information from children under 13 years old.  We will take steps to delete it if we learn we have collected it.

We do not knowingly collect, maintain or use Personal Information from children under 13 years old, and no part of the Sites is directed to children under the age of 13. If you learn that your child has provided us with Personal Information without your consent, you may alert us at communications@mylan.com. If we learn that we have collected any Personal Information from children under 13 years old, we will promptly take steps to delete such information and terminate the child’s account.

LINKS TO OTHER WEBSITES

As a convenience to our visitors, the Sites may contain links to the websites of another company or organization. When you click on one of these links, you will be transferred from our Sites and be connected to the website of the company or organization you selected. Our Privacy Policy does not apply when you leave our Sites.    

INTERNATIONAL USERS

By using the Sites, you will transfer data to the United States.


If you are visiting from the European Union or other regions with laws governing data collection and use, please note that you are agreeing to the transfer of your information to the United States and processing globally. By providing your information you consent to any transfer and processing in accordance with this Privacy Policy.

UPDATE YOUR INFORMATION OR POSE A QUESTION OR SUGGESTION

If you would like to update or correct any information that you have provided to us through your use of the Sites or otherwise, or if you have suggestions for improving this Privacy Policy, please send an email to communications@mylan.com or write to us at the address below.

CHANGES TO OUR PRIVACY POLICY AND PRACTICES 

We may revise this Privacy Policy, so review it periodically.


Posting of Revised Privacy Policy We will post any adjustments to the Privacy Policy on this web page, and the revised version will be effective when it is posted. If you are concerned about how your information is used, bookmark this page and read this Privacy Policy periodically.

New Uses of Personal Information From time to time, we may desire to use Personal Information for uses not previously disclosed in our Privacy Policy. If our practices change regarding previously collected Personal Information in a way that would be materially less restrictive than stated in the version of this Privacy Policy in effect at the time we collected the information, we will make reasonable efforts to provide notice and obtain consent to any such uses as may be required by law.

Contact Information

Mylan Inc.

Attn: Global Communications
1000 Mylan Boulevard
Canonsburg, PA 15317

Effective Date: Dec. 16, 2013

Last Updated Date: Dec. 16, 2013

 

EMSAM® — INDICATION AND IMPORTANT SAFETY INFORMATION

EMSAM Transdermal System is a skin patch used to treat major depressive disorder.

What is the most important information I should know about EMSAM?

  • Antidepressants may increase suicidal thoughts or actions in children, teenagers and young adults
  • Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts or feelings. This is very important when an antidepressant is started or when the dose is changed
  • Call a healthcare provider right away to report any new or sudden changes in mood, behavior, thoughts, or feelings
  • EMSAM Transdermal System is not approved for use in patients under 18 years of age

Call a healthcare provider right away if you or someone you care for have any of the following symptoms, especially if they are new, worse, or worry you:

Thoughts about suicide or dying; attempts to commit suicide; new or worse depression, anxiety or irritability; feeling very agitated or restless; panic attacks; trouble sleeping; acting aggressive, being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking; other unusual changes in behavior or mood.

  1. Do not eat or drink foods and beverages with high amounts of a substance called tyramine while on EMSAM 9 mg/24 hr or 12 mg/24 hr, and for 2 weeks after stopping these doses. Ask your healthcare professional or see the Medication Guide for a complete list of foods and drinks that must be avoided. EMSAM at any dose should not be used in children under 12 even when used with dietary modifications.
    • – Consuming tyramine-rich foods and beverages can lead to a sudden, large increase in blood pressure called “hypertensive crisis.” This is a serious medical condition that may be life-threatening. Seek immediate medical care if you experience any of these symptoms: sudden severe headache, nausea, stiff neck, vomiting, a fast or slow heartbeat or a change in the way your heart beats (palpitations), tight chest pain, a lot of sweating, confusion, dilated pupils, and sensitivity to light
  2. Tell your doctor about all medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements. Tell all of your healthcare professionals that you are using EMSAM.
    • • Due to the potential for serious and life-threatening side effects, do not use the following medicines while using EMSAM at any dose, and for 2 weeks after stopping EMSAM:
    • – Other medicines to treat depression (antidepressants) including other MAOI medicines; medicines which contain selegiline (such as Eldepryl®);  St. John’s Wort; narcotic pain medicines that contain meperidine e.g., Demerol®; pain medicines tramadol, methadone, or propoxyphene; medicines containing carbamazepine e.g., Tegretol® a seizure medicine and oxcarbazepine, e.g., Trileptal® a seizure medicine; cold / cough preparations, decongestants, over-the-counter diet pills or herbal weight-loss products containing pseudoephedrine, phenylephrine, phenylpropanolamine, dextromethorphan, or ephedrine; herbal or dietary supplements that contain tyramine; Flexeril® (cyclobenzaprine), a medicine used to treat muscle spasms; amphetamines (stimulants or “uppers”); and BuSpar® (buspirone), an anxiety medicine
    • Some of these medicines will have to be stopped for 1 week (or more) before you can start using EMSAM

What should I tell my doctor before starting EMSAM Transdermal System?

  • Tell your healthcare professional about any medical conditions, including if you:
    • – Have or had manic episodes (a mental condition that causes “high” moods)
    • – Have any heart problems
    • – Have or had seizures (convulsions or “fits”)
    • – Tend to get dizzy or faint
    • – Are planning to have surgery
    • – Are or intend to become pregnant
    • – Are breast-feeding

What are the possible side effects of EMSAM Transdermal System?

  • EMSAM may worsen your depression, give you suicidal thoughts, or cause unusual changes in behavior. Call your healthcare professional right away if you feel worse with EMSAM
  • EMSAM may cause mania or hypomania in people who have a history of mania
  • EMSAM may cause low blood pressure. Lie down if you feel dizzy, faint, or lightheaded and change positions gradually
  • The most common side effect of EMSAM is a skin irritation where the patch is placed. Other common side effects with EMSAM include: headache, difficulty sleeping, diarrhea, dry mouth

How should I use EMSAM Transdermal System?

  • Use EMSAM exactly as prescribed and do not stop or change treatment (even if you start to feel better) without talking to your health care professional
  • Use only one patch at a time and change the patch once a day (every 24 hours). If you use more than one EMSAM patch at a time, remove the patches right away and call your doctor or Poison Control at 1-800-222-1222

General advice about EMSAM Transdermal System

  • Avoid exposing the EMSAM application site to direct heat, such as heating pads, electric blankets, heat lamps, saunas, hot tubs, heated water beds, and prolonged direct sunlight
  • Do not drive or operate hazardous machinery until you know how EMSAM affects you as EMSAM can reduce your judgment, ability to think, or coordination. Avoid drinking alcohol while using EMSAM
  • Do not use EMSAM if you are allergic to anything in EMSAM. See the Medication Guide for a complete list of ingredients in EMSAM
  • If you have any questions about your health or medicines, talk to your healthcare professional

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088

Please see full Prescribing Information, including Boxed Warning and Medication Guide.